SBFM
Sunshine Biopharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.10
-0.01 ▼ -0.90%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$1.10
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -1.86 | Insider Own | 0.04% | Shs Outstand | 0.00B | Perf Week | -0.9% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | -7.56% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | - | Inst Own | 5.24% | Short Float | 4.61% | Perf Quarter | -24.66% |
| Income | -0.01B | P/S | 0.14 | EPS this Y | - | Inst Trans | -2.23% | Short Ratio | 5 | Perf Half Y | -25.68% |
| Sales | 0.04B | P/B | 0.21 | EPS next 5Y | - | ROA | -19.47% | Short Interest | 0.23M | Perf YTD | -10.57% |
| Book/sh | 5.31 | P/C | 0.58 | EPS past 3/5Y | 98.43% 82.07% | ROE | -24.34% | 52W High | -71.79% ($3.90) | Perf Year | -42.41% |
| Cash/sh | 1.9 | P/FCF | - | Sales past 3/5Y | 434.47% 340.11% | ROIC | -24.13% | 52W Low | 4.76% ($1.05) | Perf 3Y | -99.93% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 98.8% | Gross Margin | 32.21% | Volatility(W/M) | 6.21% 4.08% | Perf 5Y | -100% |
| Dividend TTM | - | EV/Sales | -0.08 | Sales Y/Y TTM | 13.24% | Oper. Margin | -13.02% | ATR (14) | 0.05 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 2.09 | EPS Q/Q | 79.47% | Profit Margin | -16.06% | RSI (14) | 39.52 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.2 | Sales Q/Q | 11.64% | SMA20 | -4.93% ($1.16) | Beta | 1.61 | Target Price | $6 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 2025/11/11 | SMA50 | -9.2% ($1.21) | Rel Volume | 0.42 | Prev Close | $1.11 |
| Employees | 52 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | -46.15% -15.16% | SMA200 | -24.12% ($1.45) | Avg Volume(3M) | 0.05M | Price | $1.1 |
| IPO | 2009/10/30 | Option/Short | No/Yes | Trades | 82 | Volume | 18,959 | Change | -0.9% |
뉴스 로딩 중...